Two more Minnesota COVID-19 testing sites will soon offer test-to-treat options at MSP Airport, beginning June 23, and St. Paul-Midway, beginning June 27.

At community test-to-treat sites, Minnesotans can get tested for COVID-19 and, if positive and determined to be high-risk, receive a prescription for medication at the same time.

The additional test-to-treat sites come as the state resizes its overall community testing network in light of falling demand and wide testing availability across the state.

Minnesota will offer test-to-treat at two existing community testing sites: MSP Airport, beginning June 23, and St. Paul-Midway, on June 27. The federal government will support test-to-treat at MSP Airport and the Minnesota Department of Health will lead operations at St. Paul-Midway. MSP Airport will now offer rapid testing to all patients.

The two sites join three federally supported community test-to-treat sites in Brooklyn Park, Moorhead and Duluth. Since opening earlier this month, the sites have prescribed medication to more than 300 Minnesotans.

“COVID-19 medication is a very important tool in our toolbox to help prevent severe disease and keep people out of the hospital, and test-to-treat makes it easier for eligible Minnesotans to receive these medicines,” said Minnesota Commissioner of Health Jan Malcolm. “Minnesotans who feel ill and are at high-risk of severe COVID-19 should visit a test-to-treat site or speak to their health care provider to see if medication is right for them. We are grateful to our federal partners and testing site hosts who are helping us make these resources more accessible.”

All of the community test-to-treat sites will continue to test Minnesotans at no cost. Minnesotans who test positive for COVID-19 via a rapid antigen test will be able to choose to be evaluated on site by a clinician and be given a prescription for the antiviral medication Paxlovid if it is deemed appropriate. Walk-ins are accepted but appointments are recommended at mn.gov/covid19.

MDH and its testing partners are working with the Board of Pharmacy to complete the steps necessary for dispensing medication on-site at test-to-treat locations. Until that is authorized, prescriptions are sent to either a pharmacy of a patients’ choosing or a nearby pharmacy to be filled.

Minnesotans seeking medication at community test-to-treat sites should be prepared to provide details of their medical history, particularly their current medications, to the on-site clinician. Only patients deemed high risk by the clinician will receive a prescription for Paxlovid.

COVID-19 therapeutics are not right for everyone, but they can reduce severe illness or risk of hospitalization among patients who are unvaccinated, elderly, or have other risk factors. Learn more about COVID-19 medication on the Minnesota COVID-19 Response website.

The new community test-to-treat locations will join the existing 61 test-to-treat sites that are already operating statewide across Minnesota, mostly located at clinics or pharmacies with Minute Clinics. Minnesotans can find other test-to-treat sites using the federal government’s Test to Treat locator. Some sites may require appointments.

Outside of the test-to-treat program, medications are available through Minnesotans’ health care providers. Minnesotans who test positive for COVID-19 should reach out to their doctor or health care provider to see if treatment is right for them.

To accommodate test-to-treat at MSP Airport, the site’s Community Vaccination operation will close effective June 30. Minnesotans can find other vaccination locations at mn.gov/vaccine.

Because testing demand is falling rapidly around Minnesota, to preserve state resources and capacity for any future case surge, and due to widely available free testing through other providers, MDH is resizing its Community Testing network.

Free COVID-19 testing is available from providers including clinics and pharmacies. Minnesotans can receive free at-home rapid testing in the mail from the state (at “order your free at-home rapid tests”) and federal governments (at COVID.gov) and through reimbursement from health insurers.